FDA — authorised 26 August 2011
- Application: NDA202570
- Marketing authorisation holder: PF PRISM CV
- Local brand name: XALKORI
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Crizotinib Capsules in United States
FDA authorised Crizotinib Capsules on 26 August 2011
Marketing authorisation
Other Oncology approved in United States
Frequently asked questions
Is Crizotinib Capsules approved in United States?
Yes. FDA authorised it on 26 August 2011.
Who is the marketing authorisation holder for Crizotinib Capsules in United States?
PF PRISM CV holds the US marketing authorisation.